Browse > Article
http://dx.doi.org/10.9718/JBER.2022.43.4.199

ISO14971:2019 detailed analysis and Post Market Surveillance Application Method - Focusing on IVDR requirements  

Knag, Il Kyu (Department of Medical Device Management and Research, SAIHST, Sungkyunkwan University)
Publication Information
Journal of Biomedical Engineering Research / v.43, no.4, 2022 , pp. 199-213 More about this Journal
Abstract
EN ISO 14971:2012 a risk management standard approved and applied as a European standard in 2012, will be adopted and applied as ISO 14971:2019 published in December 2019, ISO/TR 24971(Guidance) published in June 2020 from May 2022. After that, it is applied to IVDD surveillance and IVDR new and conversion, and the manufacturer is already preparing for application or is starting preparation for application. In addition, 98/78/EEC IVDD applied from 1998 will also be applied as REGULATION (EU) 2017/746 IVDR from May 2022. In particular, in IVDR, the requirements for post-marketing investigations such as Post Market Surveillance (PMS), Summary of safety and performance(SSP), Periodic Safety Update Report(PSUR) and Post Market Performance Follow Up(PMPF), which were not required in the existing IVDD, increased, and the contents were also specified. This study focused on ISO14971:2019 among these strengthened and newly applied regulations, and tried to present a detailed analysis and application plan of Post Market Surveillance (PMS) required by 2017/746 IVDR.
Keywords
ISO14971; Risk management; Post market surveillance (PMS); In vitro diagnostic medical device (IVD);
Citations & Related Records
연도 인용수 순위
  • Reference
1 MDCG 2019-9, Rev.0, Summary of safety and clinical performance A guide for manufacturers and notified bodies. 2019, pp. 21-24.
2 MFDS.「Regulations on In Vitro Diagnostic Medical Device Items and Classification by Item」. 2020, pp. 8-38.
3 ISO 13485:2016: Medical devices, Quality management systems - Requirements for regulatory purposes. 2016, pp. 6.
4 ISO 14971:2019: Medical devices, Application of risk management to medical devices. 2019, pp. 1-7.
5 ISO/TR 24971:2020: Medical devices, Guidance on the application of ISO 14971. 2020, pp. 63-85.
6 MEDDEV 2.12/1 Rev. 8, GUIDELINES ON A MEDICAL DEVICES VIGILANCE SYSTEM. 2013, pp. 13-26.
7 MEDDEV 2.12/2 Rev. 2, GUIDELINES ON MEDICAL DEVICES, POST MARKET CLINICAL FOLLOW-UP STUDIES, A GUIDE FOR MANUFACTURERS AND NOTIFIED BODIES. 2012, pp. 8-14.
8 Min Woo Kang. Risk management application plan according to ISO14971:2019-Analysis through risk management of VR medical devices. Medical Device Engineering and Management. The Graduate School, Yonsei University. 2020, pp. 10-13.
9 MDCG 2021-1, Rev.1, Guidance on harmonised administrative practices and alternative technical solutions until EUDAMED is fully functional. 2021, pp. 23.
10 ISO 14971:2007: Medical devices, Application of risk management to medical devices. 2007, pp. 1-5.
11 DIRECTIVE 98/79/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 1998, pp. 25.
12 EU IVDR REGULATION (EU) 2017/746 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. 2017;65.
13 NB-MED/2.12/Rec1 - Post-Marketing Surveillance(PMS) post market/production MINISTRY DECREE. 2005;1-9.
14 MDCG 2020-7, Rev.0, Post-Market Clinical Follow-up (PMCF) Plan Template A guide for manufacturers and notified bodies. 2020, pp. 5-12.
15 MDCG 2020-8, Rev.0, Post-Market Clinical Follow-up (PMCF) Evaluation Report Template A guide for manufacturers and notified bodies. 2020, pp. 4-9.
16 MDITAC. Post-sales clinical follow-up care guidelines. 2012, pp. 4-6.
17 NIDS. Standard Trend Expert Newsletter, ISO 14971:2019 Major Revisions and Implications. 2020, pp. 4-11.
18 MFDS. 「In vitro diagnostic medical device manufacturing and quality control standards」. 2020, pp. 31.